North America Hepatitis B Infection Market
Market Report I 2024-09-01 I 157 Pages I Data Bridge Market Research
The North America hepatitis B infection market is expected to reach USD 3.45 billion by 2031 from USD 2.35 billion in 2023, growing at a CAGR of 4.9% in the forecast period of 2024 to 2031.
Market Segmentation:
North America Hepatitis B Infection Market Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery, By Countries (U.S., Canada and Mexico)- Industry Trends and Forecast to 2031
Overview of North America Hepatitis B Infection Market Dynamics:
Driver
- Increasing prevalence of hepatitis B infections
Restraint
- Side effects and drug resistance
Opportunity
- Advanced research and development for clinical trials
Market Players:
The key market players operating in the North America hepatitis B infection market are listed below:
- Gilead Sciences, Inc.
- GSK plc
- Dynavax Technologies
- Bristol-Myers Squibb
- F. Hoffmann-La Roche Ltd
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF NORTH AMERICA HEPATITIS B INFECTION MARKET 21
1.4 MARKETS COVERED 24
2 MARKET SEGMENTATION 26
2.1 MARKETS COVERED 26
2.2 GEOGRAPHICAL SCOPE 27
2.3 YEARS CONSIDERED FOR THE STUDY 28
2.4 CURRENCY AND PRICING 28
2.5 DBMR TRIPOD DATA VALIDATION MODEL 29
2.6 MULTIVARIATE MODELLING 32
2.7 THERAPEUTICS LIFELINE CURVE 33
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.9 DBMR MARKET POSITION GRID 35
2.10 VENDOR SHARE ANALYSIS 36
2.11 SECONDARY SOURCES 37
2.12 ASSUMPTIONS 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHT 43
4.1 PESTAL ANALYSIS 44
4.2 PORTER FIVE FORCES 45
5 NORTH AMERICA HEPATITIS B INFECTION MARKET: REGULATIONS 46
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION 46
5.2 NORTH AMERICA REGULATORY SCENARIO 54
5.3 EUROPE REGULATORY SCENARIO 62
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO 66
5.5 SOUTH AMERICA REGULATORY SCENARIO 71
6 PIPELINE ANALYSIS 76
7 EPIDEMILIOGY 87
8 MARKET OVERVIEW 89
8.1 DRIVERS 91
8.1.1 INCREASING PREVALENCE OF HEPATITIS B INFECTIONS 91
8.1.2 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS 92
8.1.3 DEVELOPMENT OF COMBINATION THERAPIES FOR HEPATITIS B 93
8.1.4 STRATEGIC INITIATIVES BY COMPANIES FOR HEPATITIS B INFECTION 94
8.2 RESTRAINTS 95
8.2.1 SIDE EFFECTS AND DRUG RESISTANCE 95
8.2.2 INSUFFICIENT VACCINE COVERAGE FOR HEPATITIS B INFECTION 96
8.3 OPPORTUNITY 97
8.3.1 RISING NEW DRUG RELEASES AND INCREASING NEW DRUG PERMITS FOR HEPATITIS B 97
8.3.2 GOVERNMENT PROGRAMS TO RAISE AWARENESS OF HEPATITIS B INFECTION 98
8.3.3 ADVANCED RESEARCH AND DEVELOPMENT FOR CLINICAL TRIALS 99
8.4 CHALLENGES 100
8.4.1 THE COST OF HEPATITIS B TREATMENTS IS HIGH 100
8.4.2 STRINGENT REGULATORY POLICIES AND REGIONAL DISPARITIES IN TREATMENT ACCESS 101
9 NORTH AMERICA HEPATITIS B INFECTION MARKET, BY TYPE 102
9.1 OVERVIEW 103
9.2 CHRONIC 106
9.3 ACUTE 106
10 NORTH AMERICA HEPATITIS B INFECTION MARKET, BY TREATMENT 107
10.1 OVERVIEW 108
10.2 VACCINE 111
10.2.1 HOSPITAL PHARMACIES 111
10.2.2 DRUGS STORES AND RETAIL PHARMACIES 111
10.2.3 ONLINE PHARMACIES 111
10.3 ANTIVIRAL DRUGS 112
10.3.1 TENOFOVIR ALAFENAMIDE FUMARATE (TAF) 112
10.3.2 TENOFOVIR DISOPROXIL FUMARATE (TDF) 112
10.3.3 ENTECAVIR 112
10.3.4 OTHERS 112
10.4 IMMUNE MODULATOR DRUGS 113
10.4.1 PEGYLATED INTERFERON 113
10.4.2 INTERFERON ALPHA 113
10.5 SURGERY 114
11 NORTH AMERICA HEPATITIS B INFECTION MARKET, BY REGION 115
11.1 NORTH AMERICA 117
11.1.1 U.S 119
11.1.2 CANADA 121
11.1.3 MEXICO 123
12 NORTH AMERICA HEPATITIS B TREATMENT MARKET: COMPANY LANDSCAPE 125
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT ANALYSIS 126
14 COMPANY PROFILE 127
14.1 GILEAD SCIENCES, INC. 127
14.1.1 COMPANY SNAPSHOT 127
14.1.2 REVENUE ANALYSIS 127
14.1.3 COMPANY SHARE ANALYSIS 128
14.1.4 PRODUCT PORTFOLIO 128
14.1.5 RECENT DEVELOPMENT 128
14.2 GLAXOSMITHKLINE PLC 130
14.2.1 COMPANY SNAPSHOT 130
14.2.2 REVENUE ANALYSIS 130
14.2.3 COMPANY SHARE ANALYSIS 131
14.2.4 PRODUCT PORTFOLIO 131
14.2.5 RECENT DEVELOPMENT 131
14.3 DYNAVAX TECHNOLOGIES CORPORATION 133
14.3.1 COMPANY SNAPSHOT 133
14.3.2 REVENUE ANALYSIS 133
14.3.3 COMPANY SHARE ANALYSIS 134
14.3.4 PRODUCT PORTFOLIO 134
14.3.5 RECENT DEVELOPMENTS 134
14.4 F. HOFFMAN-LA ROCHE LTD. 136
14.4.1 COMPANY SNAPSHOT 136
14.4.2 REVENUE ANALYSIS 136
14.4.3 COMPANY SHARE ANALYSIS 137
14.4.4 PRODUCT PORTFOLIO 137
14.4.5 RECENT DEVELOPMENTS 137
14.5 BRISTOL-MYERS SQUIBB COMPANY 138
14.5.1 COMPANY SNAPSHOT 138
14.5.2 REVENUE ANALYSIS 138
14.5.3 COMPANY SHARE ANALYSIS 139
14.5.4 PRODUCT PORTFOLIO 139
14.5.5 RECENT DEVELOPMENTS 139
14.6 ARROWHEAD PHARMACEUTICALS, INC. 140
14.6.1 COMPANY SNAPSHOT 140
14.6.2 REVENUE ANALYSIS 140
14.6.3 PRODUCT PORTFOLIO 141
14.6.4 RECENT DEVELOPMENTS 141
14.7 ARBUTUS BIOPHARMA 142
14.7.1 COMPANY SNAPSHOT 142
14.7.2 REVENUE ANALYSIS 142
14.7.3 PRODUCT PORTFOLIO 143
14.7.4 RECENT UPDATES 143
14.8 AUROBINDO PHARMA 144
14.8.1 COMPANY SNAPSHOT 144
14.8.2 REVENUE ANALYSIS 144
14.8.3 PRODUCT PORTFOLIO 145
14.8.4 RECENT UPDATES 145
14.9 LUPIN PHARMACEUTICALS, INC. 146
14.9.1 COMPANY SNAPSHOT 146
14.9.2 PRODUCT PORTFOLIO 146
14.9.3 RECENT UPDATES 147
14.10 MERCK & CO., INC., 148
14.10.1 COMPANY SNAPSHOT 148
14.10.2 REVENUE ANALYSIS 148
14.10.3 PRODUCT PORTFOLIO 149
14.10.4 RECENT DEVELOPMENTS 149
14.11 NOVARTIS AG 150
14.11.1 COMPANY SNAPSHOT 150
14.11.2 REVENUE 150
14.11.3 PRODUCT PORTFOLIO 151
14.11.4 RECENT DEVELOPMENT 151
14.12 TEVA PHARMACEUTICAL INDUSTRIES 152
14.12.1 COMPANY SNAPSHOT 152
14.12.2 PRODUCT PORTFOLIO 152
14.12.3 RECENT DEVELOPMENTS 152
14.13 ZYDUS PHARMACEUTICALS, INC. 153
14.13.1 COMPANY SNAPSHOT 153
14.13.2 PRODUCT PORTFOLIO 153
14.13.3 REVENUE 154
14.13.4 RECENT DEVELOPMENT 154
15 QUESTIONNAIRE 155
16 RELATED REPORTS 157
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.